ContraFect

CFRX NASDAQ
0.4400
-0.0499
-10.19%
盘前: 0.4400 0 0.00% 08:54 07/19 EDT
开盘
0.4899
昨收
0.4899
最高
0.4900
最低
0.4203
成交量
29.50万
成交均量(3M)
61.58万
52周最高
2.629
52周最低
0.3550
换手率
0.37%
市值
3,494.02万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供ContraFect CFRX股票价格,ContraFect股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

ContraFect Corporation is a clinical-stage biotechnology company. The Company is focused on discovering and developing therapeutic protein and antibody products for the treatment of infectious diseases, including those caused by drug-resistant pathogens, particularly those treated in hospital settings. Its pipeline of lysin candidates includes CF-301, CF-302, CF-303, CF-309, CF-304, CF-305, CF-306, CF-307 and CF-308. Its other product candidate includes CF-404. Its lysin product candidate, CF-301 is developed for the treatment of Staph aureus bacteremia, including endocarditis, caused by methicillin-resistant Staph aureus and susceptible Staph aureus strains. Its product candidate, CF-404 is used for the treatment of human influenza, including seasonal and pandemic varieties. It focuses on addressing drug-resistant infections using product candidates from its lysin and monoclonal antibody platforms that target conserved regions of either bacteria or viruses.
展开 >

最近浏览

名称
价格
涨跌幅